Hotline:
+ 49 (0) 2204 2918806

Market studies for category L

Items 1 to 10 of 346 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 35
  1. Net price*
    Year
  2. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    ChemoCentryx, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    38 pages
    Global Market Direct’s pharmaceuticals report, “ChemoCentryx, Inc. - Product Pipeline Review - 2013” provides data on the ChemoCentryx, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This repo
    Englisch | Zukunftsanalyse | SKU: 361749
  3. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2013

    Global Markets Direct
    41 pages
    Global Markets Direct’s, 'Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis), complete with latest updates, and special features on late-stage and discon
    Englisch | Zukunftsanalyse | SKU: 361813
  4. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Other Central Nervous System Disorders - Pipeline Review, H2 2013

    Global Markets Direct
    45 pages
    Global Markets Direct’s, 'Other Central Nervous System Disorders - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Other Central Nervous System Disorders, complete with latest updates, and special features on late-stage and di
    Englisch | Zukunftsanalyse | SKU: 361877
  5. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Soft Tissue Sarcoma - Pipeline Review, H2 2013

    Global Markets Direct
    218 pages
    Global Markets Direct’s, 'Soft Tissue Sarcoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Soft Tissue Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews k
    Englisch | Zukunftsanalyse | SKU: 361941
  6. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Fecal Incontinence - Pipeline Review, H2 2013

    Global Markets Direct
    33 pages
    Global Markets Direct’s, 'Fecal Incontinence - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Fecal Incontinence, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key
    Englisch | Zukunftsanalyse | SKU: 361653
  7. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Relapsed Multiple Myeloma - Pipeline Review, H2 2013

    Global Markets Direct
    169 pages
    Global Markets Direct’s, 'Relapsed Multiple Myeloma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Relapsed Multiple Myeloma, complete with latest updates, and special features on late-stage and discontinued projects. It al
    Englisch | Zukunftsanalyse | SKU: 361717
  8. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Cellmid Limited - Product Pipeline Review - 2013

    Global Markets Direct
    25 pages
    Global Market Direct’s pharmaceuticals report, “Cellmid Limited - Product Pipeline Review - 2013” provides data on the Cellmid Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is
    Englisch | Zukunftsanalyse | SKU: 361781
  9. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    FIT Biotech Oyj - Product Pipeline Review - 2013

    Global Markets Direct
    24 pages
    Global Market Direct’s pharmaceuticals report, “FIT Biotech Oyj - Product Pipeline Review - 2013” provides data on the FIT Biotech Oyj’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is
    Englisch | Zukunftsanalyse | SKU: 361845
  10. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Rabies - Pipeline Review, H2 2013

    Global Markets Direct
    71 pages
    Global Markets Direct’s, 'Rabies - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Rabies, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the
    Englisch | Zukunftsanalyse | SKU: 361909
  11. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Polio - Pipeline Review, H2 2013

    Global Markets Direct
    49 pages
    Global Markets Direct’s, 'Polio - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Polio, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the t
    Englisch | Zukunftsanalyse | SKU: 361685

Items 1 to 10 of 346 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 35